The gene therapy developer has lost most of its value since going public in 2020 and saw a long road ahead for a delivery technology that had shown promise in preclinical tests.
Senescent cells are biochemical waste factories. A new study suggests that a way to wipe them out is a medicine already approved for eye problems. Dubbed “zombie cells,” senescent cells slowly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback